Article by Disease – Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells – Current Pharmaceutical Design

ARTICLE BY DISEASE ON “BREAST CANCER

Abstract:

The roles of the epidermal growth factor receptor (EGFR) signaling pathway in various cancers including breast, bladder, brain, colorectal, esophageal, gastric, head and neck, hepatocellular, lung, neuroblastoma, ovarian, pancreatic, prostate, renal and other cancers have been keenly investigated since the 1980’s. While the receptors and many downstream signaling molecules have been identified and characterized, there is still much to learn about this pathway and how its deregulation can lead to cancer and how it may be differentially regulated in various cell types. Multiple inhibitors to EGFR family members have been developed and many are in clinical use. Current research often focuses on their roles and other associated pathways in cancer stem cells (CSCs), identifying sites where therapeutic resistance may develop and the mechanisms by which microRNAs (miRs) and other RNAs regulate this pathway. This review will focus on recent advances in these fields with a specific focus on breast cancer and breast CSCs. Relatively novel areas of investigation, such as treatments for other diseases (e.g., diabetes, metabolism, and intestinal parasites), have provided new information about therapeutic resistance and CSCs.

Read more: http://www.eurekaselect.com/node/140187/article

New Issue :: Current Pharmaceutical Design 23, Issue 8

Current Pharmaceutical Design publishes timely in-depth reviews and research articles from leading pharmaceutical researchers in the field, covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area guest edited by an acknowledged authority in the field.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

cpd-14-16

Articles from the journal Current Pharmaceutical Design 23, Issue 8:

For details on the articles, please visit this link :: http://bit.ly/2uTs79b

 

 

 

 

 

New Issue :: Current Pharmaceutical Design 23, Issue 7

Current Pharmaceutical Design publishes timely in-depth reviews and research articles from leading pharmaceutical researchers in the field, covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area guest edited by an acknowledged authority in the field.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

cpd-14-16

Articles from the journal Current Pharmaceutical Design 23, Issue 7:

                       For details on the articles, please visit this link :: http://bit.ly/2vaJiWu

 

 

 

 

Testimonial by Zhijun Yang!

Zhijun Yang

Contributed Article: Long-lasting insulin treatment via a single subcutaneous administration of liposomes in thermoreversible Pluronic® F127 based hydrogel

Wishing A Very Happy Birthday Dr. William A. Banks!

Dr. William A. Banks-9 june

Dr. William A. Banks

Editor-in-Chief: Current Pharmaceutical Design

VAPSHCS/GRECC S-182
Building 1, Room 810A
1600 S. Columbian Way
Seattle, WA 98108
USA

Upcoming Thematic Issue – An Approach to the Theoretical and Experimental Design of Fused Compounds in the Treatment of Mental And Motor Dysfunctions

CPD- THEMATIC FLYER -Eduardo Sobarzo-Sánchez

http://benthamscience.com/journals/current-pharmaceutical-design/special-issues/#top

 

New Issue :: Current Pharmaceutical Design 23, Issue 3

Current Pharmaceutical Design publishes timely in-depth reviews and research articles from leading pharmaceutical researchers in the field, covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area guest edited by an acknowledged authority in the field.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

CPD

Articles from the journal Current Pharmaceutical Design 23, Issue 3:

For details on the articles, please visit this link :: http://bit.ly/2qB0duQ

 

Highlighted Article Flyer for the journal “Current Pharmaceutical Design”

CPD-Articles_23-46-Cristina Caleja

http://benthamscience.com/journals/current-pharmaceutical-design/

New Issue :: Current Pharmaceutical Design 23, Issue 4

Current Pharmaceutical Design publishes timely in-depth reviews and research articles from leading pharmaceutical researchers in the field, covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area guest edited by an acknowledged authority in the field.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

CPD

Articles from the journal Current Pharmaceutical Design 23, Issue 4:

                       For details on the articles, please visit this link :: http://bit.ly/2p0Uoer

 

Highlighted Article Flyer for the journal “Current Pharmaceutical Design”

CPD-Articles_23-46-Isabel C.F.R. Ferreira

http://benthamscience.com/journals/current-pharmaceutical-design/